Zymeworks (ZYME) Cash from Financing Activities (2021 - 2026)

Zymeworks has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $178.8 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $178.8 million, up 13485.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $158.9 million (up 847.78% YoY), and the FY2025 annual result was -$18.6 million, up 9.19% from the prior year.
• Cash from Financing Activities came in at $178.8 million for Q1 2026 at Zymeworks, up from -$18.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $178.8 million in Q1 2026 to a low of -$18.7 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is $1.3 million (2025), against an average of $19.4 million.
• Across the five-year window, Cash from Financing Activities jumped 13530.24% in 2023 and slumped 889.87% in 2024, its largest moves.
• Zymeworks' Cash from Financing Activities stood at -$377000.0 in 2022, then surged by 13530.24% to $50.6 million in 2023, then sank by 117.07% to -$8.6 million in 2024, then tumbled by 116.87% to -$18.7 million in 2025, then soared by 1053.93% to $178.8 million in 2026.
• The last three Cash from Financing Activities figures came in at $178.8 million (Q1 2026), -$18.7 million (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.